NervGen PharmaNGENF 
$2.031.50%24h
1.50%24h
Global rank20190
Market cap$120.80M
Change 7d0.50%
YTD Performance-0.49%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of NervGen Pharma (NGENF)
As of November 2024, NervGen Pharma has a market cap of $120.80M. This makes NervGen Pharma the world's 20190th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of NervGen Pharma from 2019 to 2024
-
Value:-
Market cap history of NervGen Pharma from 2019 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $149.24M | 22.94% |
| 2023 | $121.39M | 71.43% |
| 2022 | $70.81M | -44.13% |
| 2021 | $126.75M | 22.41% |
| 2020 | $103.54M | 10.13% |
| 2019 | $94.02M | - |
NGENF Market Cap Today is $120.80M 1.50% - 12 Nov 2024
View largest stocks by market cap 
